add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare ...Reuters - Nov 5, 2009 Mark Foletta, senior vice president of finance and chief financial officer at Amylin Pharmaceuticals, will be providing a corporate overview. ... Amylin Makes Move in Obesity Drug RaceVoice of San Diego - Nov 5, 2009 San Diego's Amylin Pharmaceuticals announced a deal this week with Japan-based Takeda Pharmaceuticals to develop and market experimental obesity drugs, ... Takeda enters partnership with Amylin Drug Store News (blog) REG-Lilly (Eli) & Co: STATEMENT ON FDA'S BYETTA (EXENATIDE) INJECTION UPDATEReuters - Nov 2, 2009 About Amylin and Lilly Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and ... FDA Issues Warning for Diabetes Drug U.S. News & World Report Amylin Pharmaceuticals Inc. Reports Operating Results (10-Q)GuruFocus.com - Nov 5, 2009 Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery development and commercialization of innovative ... Amylin to Host Presentation at Credit Suisse Healthcare ConferenceTransWorldNews (press release) - 10 hours ago Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) will present at the 18th Annual Credit Suisse Healthcare Conference on November 11th at 10:00 am (PT). ... Pharmaceuticals see proposed health care legislation as mixed bagSan Diego Daily Transcript (subscription) - - Nov 6, 2009 For instance, Amylin Pharmaceuticals in the past week announced an agreement with Takeda Pharmaceutical of Japan to develop and commercialize products for ... UPDATE 1-Amylin says Byetta gets FDA approval for new useReuters - - Oct 30, 2009 NEW YORK, Oct 30 (Reuters) - Amylin Pharmaceuticals Inc (AMLN.O) said on Friday that its Byetta drug has won US regulatory approval for use as a stand-alone ... AMLN, Green Light from FDA to Its BYETTA for Expanded Use TransWorldNews (press release) Human Genome rallies, GTX cratersMarketWatch - - Nov 2, 2009 The NYSE Arca Biotechnology Index (INDEX:BTK) , meanwhile, jumped 4% to 855.12, propelled by index components Human Genome, Amylin Pharmaceuticals and ... Amylin 3Q Loss Narrows Substantially On Cost Cuts, Tops ViewsWall Street Journal - Oct 20, 2009 Amylin Pharmaceuticals Inc.'s (AMLN) third-quarter loss narrowed more sharply than expected on cost cutting, while revenue fell short of analysts' ... Amylin Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript Seeking Alpha (blog) Amylin Pharmaceuticals said quarter losses fell San Diego Union Tribune US pharma looks to Japan as Japan eyes USFiercePharma - - Nov 5, 2009 And Japanese drugmakers have been inking development deals outside Japan as well; just think of this week's obesity-drug pact with Amylin Pharmaceuticals. ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
